Transgene Biotek (BOM:526139) FFO


BOM:526139 Transgene Biotek Ltd BOM:526139
47 GF Score
Price ₹3.04
GF Value ₹6.54
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Transgene Biotek FFO?

FFO (Funds from operations) only applies to REITs.

BOM:526139
47GF Score
Transgene Biotek Ltd BOM:526139
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Transgene Biotek (BOM:526139) Overvalued in 2026?

Based on GuruFocus' analysis, Transgene Biotek stock appears to be undervalued. The current stock price of ₹3.04 is trading 53.5% below its estimated GF Value™ of ₹6.54. GuruFocus considers Transgene Biotek to be Possible Value Trap.

Key valuation signals for BOM:526139:

  • FFO:
  • GF Value™: ₹6.54 vs. price of ₹3.04 (53.5% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the BOM:526139 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Transgene Biotek Business Description

Address Anrich Industrial Area, Plot No. 69 and 70, IDA Bollaram, Sangareddy District, Medak, TG, IND, 502325
Transgene Biotek Ltd is an India-based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and other pharmaceutical products. The company is operating only in one segment of Bulk Drugs. Its product portfolio includes TrabiDHA, Tracolimus, and Orlistat. It generates revenue from the sale of goods and services.
47GF Score

Get the complete analysis for BOM:526139

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.04
Price
₹6.54
GF Value